Patients who have rosacea are often misdiagnosed initially, which just further exacerbates an already-frustrating condition. Dermatologists and other clinicians who care for patients with facial skin conditions should be aware of the diagnosis criteria for rosacea, differential diagnoses, treatments, and self-care options. Although rosacea might negatively impact patients’ lives, utilizing proper treatments as well as educating patients on self-care strategies may improve patient outcomes and create a more positive outlook for both the patient and clinician.
Dermatologists and other healthcare professionals who provide care for patients with rosacea
At the conclusion of this activity, participants should be better able to:
Proactively ask patients about the signs and symptoms of rosacea
Assess current and emerging treatments with regard to their risks, benefits, safety profile, and limitations for each rosacea subtype
Devise patient-specific rosacea treatment plans according to subtype, severity, and other individual characteristics and needs
Conflict Of Interest Disclosure Policy
In accordance with the ACCME Standards for Commercial Support, HME requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. HME resolves all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs.
Zoe Draelos, MD Primary Investigator Dermatology Consulting Services High Point, NC
Dr. Draelos receives research fees from Aclaris Therapeutics, Allergan, Boehringer Ingelheim, BioPharmX, Foamix Pharmaceuticals, Galderma, Lilly, Menlo Therapeutics, Merck & Co., Inc., Novan, Novartis Pharmaceuticals, Pfizer, Sun Pharma, and Valeant Pharmaceuticals.
Paul Doghramji, MD Family Physician Collegeville Family Practice Medical Director, Health Services Ursinus College Collegeville, PA
Dr. Doghramji receives consulting fees from Iroko.
Accredited Provider Disclosure
Haymarket Medical Education staff involved in the planning and content review of this activity have no relevant financial relationships to disclose.
AMA PRA Category 1 Credit(s)TM
Haymarket Medical Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Haymarket Medical Education designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)TM . Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure of Unlabeled Use
This CME activity may or may not discuss investigational, unapproved, or off-label use of drugs. Participants are advised to consult prescribing information for any products discussed. The information provided in this CME activity is for continuing medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options for a specific patient’s medical condition.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of Haymarket Medical Education, the National Rosacea Society, and Allergan. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
To obtain credit, a score of 70% or better on the post-test is required. This activity is offered at no cost to participants. Please proceed with the activity until you have successfully completed this program, answered all test questions, completed the post-test and evaluation, and have received a digital copy of your credit certificate. Your online certificate will be saved on myCME within your Profile/CME History, which you can access at any time.